Moein, Anita
20  results:
Search for persons X
?
4

First‐in‐human phase 1 trial evaluating safety, pharmacokin..:

Tang, Fei ; Kunder, Rebecca ; Chu, Tom...
Clinical and Translational Science.  16 (2023)  9 - p. 1653-1666 , 2023
 
?
5

A disease model predicting placebo response and remission s..:

Moein, Anita ; Langenhorst, Jurgen ; Plan, Elodie L....
Clinical and Translational Science.  16 (2023)  11 - p. 2310-2322 , 2023
 
?
6

Exposure‐response relationships of etrolizumab in patients ..:

Kassir, Nastya ; Zhu, Rui ; Moein, Anita...
CPT: Pharmacometrics & Systems Pharmacology.  11 (2022)  9 - p. 1234-1243 , 2022
 
?
7

Population pharmacokinetic analysis of etrolizumab in patie..:

Moein, Anita ; Lu, Tong ; Jönsson, Siv...
CPT: Pharmacometrics & Systems Pharmacology.  11 (2022)  9 - p. 1244-1255 , 2022
 
?
8

Safety, Tolerability, and Pharmacokinetics of High‐Volume S..:

Dolton, Michael J. ; Chesterman, Aaron ; Moein, Anita...
Clinical Pharmacology & Therapeutics.  110 (2021)  5 - p. 1337-1348 , 2021
 
?
10

Safety, Pharmacokinetics, and Pharmacodynamics in Healthy V..:

Herman, Ann E. ; Chinn, Leslie W. ; Kotwal, Shweta G....
Clinical Pharmacology & Therapeutics.  103 (2018)  6 - p. 1020-1028 , 2018
 
?
11

First‐in‐human phase 1 trial evaluating safety, pharmacokin..:

Tang, Fei ; Kunder, Rebecca ; Chu, Tom...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499406/.  , 2023
 
?
12

Population pharmacokinetic analysis of etrolizumab in patie..:

Moein, Anita ; Lu, Tong ; Jönsson, Siv...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469700/.  , 2022
 
?
 
1-15